| P2093 | author name string | Qian Wang | |
| | Yan Zhang | |
| | Wei Liu | |
| | Junfeng Du | |
| | Xiaojuan Ren | |
| P2860 | cites work | Impact of Pregnancy on Intra-Host Genetic Diversity of Influenza A Viruses in Hospitalised Women: A Retrospective Cohort Study | Q91325307 |
| | Amino acid changes in HA and determinants of pathogenicity associated with influenza virus A H1N1pdm09 during the winter seasons 2015-2016 and 2016-2017 in Mexico | Q92839163 |
| | Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-κB and p38 MAPK pathway | Q94563280 |
| | More than just a common cold: Endemic coronaviruses OC43, HKU1, NL63, and 229E associated with severe acute respiratory infection and fatality cases among healthy adults | Q98154178 |
| | The genomic and epidemiological dynamics of human influenza A virus | Q24649077 |
| | Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases | Q34755657 |
| | Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury | Q34816925 |
| | Measuring myeloperoxidase activity in biological samples | Q34826644 |
| | The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders | Q35003250 |
| | PARP-1 inhibitor, DPQ, attenuates LPS-induced acute lung injury through inhibiting NF-κB-mediated inflammatory response | Q35053250 |
| | Global circulation patterns of seasonal influenza viruses vary with antigenic drift | Q35844377 |
| | Targeted therapy for cancer using PARP inhibitors | Q37222838 |
| | Inhibition of poly (adenosine diphosphate-ribose) polymerase attenuates lung-kidney crosstalk induced by intratracheal lipopolysaccharide instillation in rats | Q37322917 |
| | Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: differential effects on CXCR2 ligands and Duffy Antigen Receptor for Chemokines | Q37429317 |
| | Beyond DNA repair, the immunological role of PARP-1 and its siblings. | Q38089268 |
| | Poly(ADP-ribose) polymerases in double-strand break repair: focus on PARP1, PARP2 and PARP3. | Q38228791 |
| | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 |
| | Lipopolysaccharide activates ERK-PARP-1-RelA pathway and promotes nuclear factor-κB transcription in murine macrophages. | Q39385263 |
| | Role of poly(ADP-ribose) polymerase in cell-cycle checkpoint mechanisms following γ-irradiation | Q40424499 |
| | Gene knockout or pharmacological inhibition of poly(ADP-ribose) polymerase-1 prevents lung inflammation in a murine model of asthma | Q40669701 |
| | Poly(ADP-Ribose)Polymerase-1 in Lung Inflammatory Disorders: A Review. | Q41820940 |
| | Inhibition of poly(adenosine diphosphate-ribose) polymerase attenuates ventilator-induced lung injury | Q41880369 |
| | Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral | Q41933161 |
| | Redox-active protein thioredoxin-1 administration ameliorates influenza A virus (H1N1)-induced acute lung injury in mice | Q43647049 |
| | Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation | Q43871211 |
| | Inhibition of poly(ADP-ribose) polymerase prevents allergen-induced asthma-like reaction in sensitized Guinea pigs | Q44978735 |
| | PARP inhibitor, olaparib ameliorates acute lung and kidney injury upon intratracheal administration of LPS in mice | Q45340890 |
| | Infection of human retinal pigment epithelial cells with influenza A viruses. | Q45954064 |
| | Rationale and opportunities in estimating the economic burden of seasonal influenza across countries using a standardized WHO tool and manual. | Q47578512 |
| | PARP-1 inhibition ameliorates elastase induced lung inflammation and emphysema in mice | Q49885715 |
| | Combined effect of anti-high-mobility group box-1 monoclonal antibody and peramivir against influenza A virus-induced pneumonia in mice | Q57038451 |
| | Influenza Virus | Q57092131 |
| | Oral administration of patchouli alcohol isolated from Pogostemonis Herba augments protection against influenza viral infection in mice | Q83114847 |
| | Targeted therapy: ARIEL3 - broad benefit of PARP inhibitors in ovarian cancer | Q89174180 |
| P921 | main subject | olaparib | Q7083106 |
| P577 | publication date | 2020-08-31 | |
| P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
| P1476 | title | Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib ameliorates influenza-virus-induced pneumonia in mice | |